Burning Rock Biotech Limited Made Big Gain

Thu, Jan 22, 2026 at 07:22 PM

Burning Rock Biotech Limited (BNR:NASDAQ) jumped higher at $41.06, representing a gain of 34.3%. On Thu, Jan 22, 2026, BNR:NASDAQ hit a New 2-Week High of $41.06. The stock got featured on our News Catalysts scanner on Mon, Jan 05, 2026 at 02:51 AM in the 'ACQUISITION' category. From Thu, Jan 08, 2026, the stock recorded 66.67% Up Days and 50.00% Green Days

About Burning Rock Biotech Limited (BNR:NASDAQ)

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore.

Top 10 Gainers:

60 Degrees Pharmaceuticals, Inc. (SXTP:NASDAQ), 152%
IO Biotech, Inc. (IOBT:NASDAQ), 131.26%
Pheton Holdings Ltd (PTHL:NASDAQ), 105.16%
Blue Gold Limited (BGL:NASDAQ), 103.83%
Namib Minerals (NAMM:NASDAQ), 83.63%
iOThree Limited (IOTR:NASDAQ), 74.06%
Captivision Inc. (CAPT:NASDAQ), 49.63%
Ambitions Enterprise Management Co. L.L.C (AHMA:NASDAQ), 41.75%
Regencell Bioscience Holdings Limited (RGC:NASDAQ), 40.44%
Burning Rock Biotech Limited (BNR:NASDAQ), 34.33%